The role of anti-IgE (omalizumab/Xolair) in the management of severe recalcitrant paediatric atopic eczema (ADAPT): Statistical analysis plan

Tao Chen, Susan Chan, Gideon Lack, Suzie Cro, Victoria R. Cornelius*

*Corresponding author for this work

    Research output: Contribution to journalArticlepeer-review

    10 Citations (Scopus)

    Fingerprint

    Dive into the research topics of 'The role of anti-IgE (omalizumab/Xolair) in the management of severe recalcitrant paediatric atopic eczema (ADAPT): Statistical analysis plan'. Together they form a unique fingerprint.

    Medicine and Dentistry

    Biochemistry, Genetics and Molecular Biology